Prognostic significance of Ki-67 and p53 antigen expression in carcinomas of bile duct and gallbladder

Journal of Medical Investigation

Volumn 45, Issue 1-2, 1998, Pages 95-102

  Shrestha, Mitra Lal ^a   Miyake, Hidenori ^a   Kikutsuji, Toru ^a   Tashiro, Seiki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Cholangiocarcinoma; Gallbladder carcinoma; Ki 67; MIB1; p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CARCINOMA; CELL DIFFERENTIATION; CHEMISTRY; FOLLOW UP; GALLBLADDER TUMOR; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CARCINOMA; CELL DIFFERENTIATION; CHOLANGIOCARCINOMA; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; HUMANS; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032130833     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Okuda K. and the liver cancer study group of Japan : Cancer 45 : 2663-69., 1980
2. Yamaguchi K. Enjoji M : Ampullary carcinoma in patients with under 50 years of age with a poor prognosis : J Surg Onco 45 : 201-06, 1990
3. Forrest JF, Longmire WP : Carcinoma of pancreas and periampullary region. Ann Surg 89 : 129-38, 1979
4. Cameron JL, Crist WD, Sitzman V : Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161 : 120-251, 1991
5. Tompkins RK, Saundrs K, Roslyn JJ, Longmire WP. Jr : Changing patterns in diagnosis and management of bile duct cancer. Ann Surg 211, 215 : 614-20, 1990
6. Neulaus H, Hoffman W : Hilar bile duct cancer diagnostic and therapeutic strategy. Bildgebung 60 (suppl. 1) : 51-6, 1993
7. Tashiro S, Uchiro R, Hiraoka T, Tsuji T, Kuwamoto S, Saito N, Yamasaki K, Miyauchi Y : Surgical indication of and significance of portal vein resection in biliary and pancreatic cancer. Surgery 109 : 481-87, 1991
8. Meyer JS. Cell kinetic measurement in human tumors : Human Pathol 13 : 847-7, 1982
9. Hall PA, Levison DA : Review, assessment of cell proliferation in histologic material. J Clin Pathol 43 : 184-92, 1990
10. Gerdes J, Schwab U, Lemke H, Stein H : Production of mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 3-20, 1983
11. Gerdes J, Lekme H, Stein h, Wascher H-H, Schwab U, Stein H : Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody. J Immunology 133 : 1710-15, 1984
12. Hall PA, Woods AL : Immunohistochemical markers of cell proliferation, achievements, problems and prospects. Cell Tissue Kinet 23: 505-22, 1990
13. Cartottoretti G, Becker MHG, Key G, Duchow M, Schulter C, Galle J : Monoclonal antibody against recombinant parts of Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave processed formalin fixed paraffin embedded section. J Pathol 168 : 357-63, 1992
14. MC. Cormic D, Chong H, Hobbs C, Hall PA : Detection of the Ki-67 antigen in fixed and wax embedded sections with the monoclonal antibody MIB-1. Histopathopathology 22 : 355-60, 1993
15. Lee Soon C : Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in situ and invasive carcinomas of the extrahepatic biliary tract. : Cancer 78 : 1881-87, 1996
16. Kawamura T, Goseki N, Koike M, Takizawa T, Endo M : Acceleration of proliferative activity of esophageal carcinoma with invasion beyond the mucosa. Cancer 77 : 843-49, 1996
17. Oya M, Yato T, Nagai E, Tsureyoshi M: Metastasizing intramural gastric carcinomas, well-differentiated type and proliferative activity using proliferative nuclear antigen and Ki-67. Cancer 75 : 926-35, 1995
18. Ming T, Wee A, Gangaraju CR : An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 74 : 1542-45, 1994
19. Lee YC, Song SY, Chung JB, Kang JK, Park IS : p53 expression in extrahepatic bile duct carcinomas. Yon Sei Medical Journal 37 : 112-7, 1996
20. Irene OL, Jia NA, Edward CS, Fan ST, Matthew NG : Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1a comparison with proliferating cell nuclear antigen. Anatomic Pathology 104 : 313-318, 1995
21. Kastan MB, Okyekemere O, Sidransky D : Participation of p53 protein in cellular response to DNA. Cancer Research 51: 6504-11, 1991
22. Milner J, Medceff EA : Co-translation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant confirmation. Cell 65 : 765-74, 1991
23. Linder S, Parrado C, Falmer UG, Blasjo M, Sudelin P, Rosen A : Prognostic significant of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma : a study of monoclonal antibodies MIB-1 and DO-7 in formalin fixed paraffin embedded tumor material. Br J Cancer 76:54-59, 1997
24. Leveine A J, Mohamad J, Finaly CA : The p53 tumor suppressor gene : Nature 351 : 453-6, 1991
25. Isobe M, Emmanuel BS, Givol D, Cren M, Croce CM : Location of the gene for human p53 tumor antigen to band 17 p 1. Nature 320 : 84-5, 1986
26. Banks L, Matlashewski G, Crawford L : Isolation of p53 specific antibodies and their use in the studies of human p 53 expression. Eur J Biochemistry 159 : 529-34, 1986
27. Iggo R, Gatter K, Bartec J, Harris AL : Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 335 : 675-9, 1990
28. Barken J, Bartkova J, Vojtesek B, Staskwa Z, Rejthar A, Kovario A : Pattern of expression of p53 tumor suppressor gene in human breast tissues in situ and in vitro. Int J Cancer 41: 837-41, 1990
29. Martin HM, Flipe MI, Morris RW, Lane DP, Silvestre F : p53 expressions and prognosis in gastric cancer. Int J Cancer 50 : 859-62, 1992
30. Hurlimann J, Sagara EP : Expression of p53 in gastric carcinomas association with histologic type and prognosis. Am J Surg Pathol 18 : 1247-53, 1994
31. Leaned E, Garland S, Seri G, Marui FA, Perinea G, Scampini S : PCNA and MIB1 in breast carcinoma correlation with clinical and biological variables. J Clin Pathol 45 : 416-9, 1992
32. Derrico A, Garbisa S, Liotta LA, Castronovo G, Stelter-Stervon WG : Agumentation of type IV collagenease, lamin in receptor and Ki-67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 97 (suppl. 1) : 521-528, 1991
33. Salem CE, Tomasic NA, Elmajian DA, Peter DE, Nicholas WN : p53 protein expression and gene alterations in pathologic stage C prostate carcinoma. J Urology 158 : 510-514, 1997
34. Coggi G, Bosari S, Graziani B, Viale G, Buffa R, Ferrero S, PIazza M, Blandamura S, Segalin A, Bonavia R, Perchhia A : p53 protein accumulation and p 53 gene mutation in esophageal carcinoma molecular and immunohistochmical study with clinicopathological correlation. Cancer 79 : 425-431, 1997
35. Dorandu A, Raol JL, Siriser F, Leclercq-Riox, Gosselin M, Martin ED, Ramee MP, Launoius B : Carcinoma of ampulla of Vater : prognostic factors after curative surgery : a series of 45 cases. Gut 40 : 350-355, 1997
36. Scarpa A, Capelli P, Zamboni G, Oda Y, Mukai K, Bonneti F : Neoplasia of ampulla of Vater. Am J Pathol 142 : 1163-72, 1993